Norway - Hospital Average Length of Stay for Malignant Neoplasm of Prostate
Since 2014, Norway Hospital Average Length of Stay for Malignant Neoplasm of Prostate was down by 0.5% year on year. In 2019, the country was ranked number 28 among other countries in Hospital Average Length of Stay for Malignant Neoplasm of Prostate at 4 Days. Norway is overtaken by Sweden, which was ranked number 27 with 4.4 Days and is followed by Australia at 3.9 Days. South Korea topped the ranking with 15.9 Days in 2019, that is stable versus 2018. New Zealand, Lithuania and Slovakia respectively ranked number 2, 3 and 4 in this ranking. New Zealand recorded the best 5 years average growth at +2.2% per year, while Mexico recorded the worst performance at -8.8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 4.00 |
| 2018 | 3.80 |
| 2017 | 3.80 |
| 2016 | 3.90 |
| 2015 | 4.00 |
Download all data from 1980 to 2019
How does Norway rank in Hospital Average Length of Stay for Malignant Neoplasm of Prostate?
| # | 32 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
15.90 | 2019 | +0.0 % | -0.9 % | View data | |
| 2 |
#2
New Zealand
|
11.60 | 2019 | -0.8 % | +2.2 % | View data | |
| 27 |
#27
Sweden
|
4.40 | 2019 | +0.0 % | -2.5 % | View data | |
| 28 |
#28
Norway
|
4.00 | 2019 | +5.3 % | -0.5 % | View data | |
| 29 |
#29
Australia
|
3.90 | 2019 | -2.5 % | -2.8 % | View data | |